Re: Zetia vs Niaspan Merck is preparing to defend its drug, said Chief Executive Officer Richard T. Clark. <b>Doctors shouldn’t change how they treat patients based on the findings</b>, he said. If this is not an admission that Niaspan won, I’m not sure what it is.